Concepedia

Publication | Open Access

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

111

Citations

12

References

2009

Year

Abstract

The results from this retrospective analysis supported imatinib dose escalation as an appropriate initial option for patients with CML-CP who were experiencing suboptimal cytogenetic response or resistance.

References

YearCitations

Page 1